Back to the drug test guide

PCP Test Evidence

Has Caused a False Positive

Mesoridazine

Source Long et al., Clin Chem 1996

What It Found

  • A patient’s urine screened positive for PCP by EMIT II and was negative by GC-MS.
  • Both thioridazine and its metabolite mesoridazine were present.

Keep in Mind

  • The case cannot identify which compound produced the signal.

Test Studied

  • EMIT II PCP in a patient’s urine

2 sources Krasowski et al., BMC Emerg Med 2009 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • Separate specificity data found cross-reactivity to mesoridazine on three assays.

Keep in Mind

  • Laboratory thresholds varied from 24 to 400 micrograms/mL depending on the reagent.

Test Studied

  • Historical Abbott, Syva and Biosite specificity data

Methylenedioxypyrovalerone

Source Macher and Penders, Drug Test Anal 2013

What It Found

  • A published report attributed false-positive PCP immunoassay results to MDPV, a synthetic cathinone.

Keep in Mind

  • The indexed letter has no abstract.
  • This is a specific report, and the method details and frequency are unverified here.

Test Studied

  • Urine PCP immunoassay in a published report

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Methylenedioxypyrovalerone challenge, Microgenics DRI Phencyclidine gave a positive result at 3.5 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Thioridazine

Source Long et al., Clin Chem 1996

What It Found

  • A patient’s urine screened positive for PCP by EMIT II and was negative by GC-MS.
  • Both thioridazine and its metabolite mesoridazine were present.

Keep in Mind

  • The urine case cannot distinguish the parent medicine from its metabolite.

Test Studied

  • EMIT II PCP in a patient’s urine

2 sources Krasowski et al., BMC Emerg Med 2009 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • In separate manufacturer data, thioridazine reacted on Abbott AxSYM at a very high concentration.

Keep in Mind

  • The AxSYM concentration does not establish the likelihood at a prescribed dose.

Test Studied

  • Historical Abbott AxSYM specificity data

Tramadol

2 sources Ly et al., Ann Emerg Med 2012 Hull et al., Am J Forensic Med Pathol 2006

What It Found

  • Several overdose cases produced PCP-positive urine.
  • Laboratory experiments with tramadol and its metabolites supported cross-reactivity.

Keep in Mind

  • Concentrations in overdose reports can be much higher than with typical dosing.

Test Studied

  • Siemens Syva EMIT II and EMIT II Plus PCP screens

Source Rengarajan and Mullins, Clin Toxicol (Phila) 2013

What It Found

  • A separate emergency department study found tramadol was associated with unconfirmed screens.

Venlafaxine

Source Bond et al., J Toxicol Clin Toxicol 2003

What It Found

  • A venlafaxine overdose produced a positive Abbott AxSYM result with no PCP by GC-MS.
  • Adding venlafaxine and its active metabolite to urine reproduced the result.

Keep in Mind

  • The Abbott spiking experiment used very high concentrations.

Test Studied

  • Abbott AxSYM PCP

3 sources Sena et al., Clin Chem 2002 Kim et al., Case Rep Psychiatry 2023 Landy and Kripalani, BJPsych Bull 2015

What It Found

  • Separate reports describe possible interference during prescribed use.

Test Studied

  • Other rapid urine PCP immunoassays

Source Landy and Kripalani, BJPsych Bull 2015

What It Found

  • Two patients taking prescribed venlafaxine repeatedly screened positive for PCP in a rehabilitation center.

Keep in Mind

  • The two rehabilitation cases had other prescriptions, and the authors did not report mass-spectrometric confirmation for either.

Desvenlafaxine

Source Farley et al., BMJ Case Rep 2017

What It Found

  • A case report linked a presumptive PCP result with prescribed desvenlafaxine.

Keep in Mind

  • The prescription case described the link as likely.
  • Independent confirmation was unavailable in that case.

Test Studied

  • Medtox PCP urine screen

Both sources Farley et al., BMJ Case Rep 2017 Sena et al., Clin Chem 2002

What It Found

  • Desvenlafaxine is also the active metabolite implicated in studies of venlafaxine.

Lamotrigine

All 4 sources Geraci et al., Int J Emerg Med 2010 Murphy et al., J Emerg Nurs 2019 McCain et al., Prim Care Companion CNS Disord 2018 Cole, Am J Emerg Med 2022

What It Found

  • Several reports describe positive rapid PCP screens in people taking lamotrigine.

Keep in Mind

  • Confirmation varied between reports.

Source Geraci et al., Int J Emerg Med 2010

What It Found

  • In an early two-patient report, broader testing was negative in one patient and the other was assessed from history.

Test Studied

  • Bio-Rad TOX/See

3 sources Murphy et al., J Emerg Nurs 2019 McCain et al., Prim Care Companion CNS Disord 2018 Cole, Am J Emerg Med 2022

What It Found

  • Further reports describe the finding on other rapid systems.

Source Cole, Am J Emerg Med 2022

Keep in Mind

  • The 2022 report used blood for confirmation of a urine result and involved other medications.

Source Murphy et al., J Emerg Nurs 2019

Test Studied

  • PROFILE-V MEDTOXScan

4-MePPP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-MePPP challenge, Microgenics DRI Phencyclidine gave a positive result at 18.5 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

4-MPBP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-MPBP challenge, Microgenics DRI Phencyclidine gave a positive result at 9 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

5-MeO-DALT

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-MeO-DALT challenge, Microgenics DRI Phencyclidine gave a positive result at 78 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Alpha-PBP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Alpha-PBP challenge, Microgenics DRI Phencyclidine gave a positive result at 4.6 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Alpha-PPP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Alpha-PPP challenge, Microgenics DRI Phencyclidine gave a positive result at 7 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Alpha-PVP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Alpha-PVP challenge, Microgenics DRI Phencyclidine gave a positive result at 1.45 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Alpha-PVT

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Alpha-PVT challenge, Microgenics DRI Phencyclidine gave a positive result at 0.6 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

D2PM

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the D2PM challenge, Microgenics DRI Phencyclidine gave a positive result at 65 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

MDPBP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the MDPBP challenge, Microgenics DRI Phencyclidine gave a positive result at 24 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

MDPPP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the MDPPP challenge, Microgenics DRI Phencyclidine gave a positive result at 60 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Meperidine

2 sources Krasowski et al., BMC Emerg Med 2009 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The assay comparison reported meperidine cross-reactivity at high urine concentrations.

Keep in Mind

  • Cross-reactivity depends on the assay and concentration.

Test Studied

  • Historical Abbott ARCHITECT and Syva EMIT PCP assays

Source Krasowski et al., BMC Emerg Med 2009

What It Found

  • One unconfirmed Syva EMIT positive contained high levels of both meperidine and dextromethorphan.

Keep in Mind

  • The patient sample does not identify which drug caused the signal.

Source Parsons et al., Clin Chem 1993

What It Found

  • The original Advisor study obtained a positive PCP result from Meperidine at 100 mg/L of drug-free urine, with no reaction at 10 mg/L.

Keep in Mind

  • These were fortified samples and high laboratory concentrations.
  • Ordinary-dose clinical detection was not tested.

Test Studied

  • Abbott Advisor PCP urine immunoassay

Methoxetamine

Source Gomila et al., J Anal Toxicol 2019

What It Found

  • The ketamine analog methoxetamine showed weak cross-reactivity in a laboratory comparison of PCP screens.

Keep in Mind

  • Reactivity was only 0.04% to 0.25%, and the investigators emphasized limited detectability.

Test Studied

  • Five commercial PCP immunoassays

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Methoxetamine challenge, Microgenics DRI Phencyclidine gave a positive result at 90 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Metronidazole

Source Fernández et al., Clin Toxicol (Phila) 2018

What It Found

  • A report identified metronidazole interference on a PCP screen.

Both sources Fernández et al., Clin Toxicol (Phila) 2018 Saitman et al., J Anal Toxicol 2026

What It Found

  • Added metronidazole produced a positive response in urine on the tested device.

Keep in Mind

  • The laboratory concentration was high.
  • This finding does not establish a probability during usual treatment.

Test Studied

  • One-step multi-analyte urine drug screen

MOPPP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the MOPPP challenge, Microgenics DRI Phencyclidine gave a positive result at 26 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

MPHP (study designation)

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the MPHP challenge, Microgenics DRI Phencyclidine gave a positive result at 1.7 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Naphyrone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Naphyrone challenge, Microgenics DRI Phencyclidine gave a positive result at 11 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Pyrovalerone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Pyrovalerone challenge, Microgenics DRI Phencyclidine gave a positive result at 2 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Trihexyphenidyl

Source Parsons et al., Clin Chem 1993

What It Found

  • The original Advisor study obtained a positive PCP result from Trihexyphenidyl at 100 mg/L of drug-free urine, with no reaction at 10 mg/L.

Keep in Mind

  • These were fortified samples and high laboratory concentrations.
  • Ordinary-dose clinical detection was not tested.

Test Studied

  • Abbott Advisor PCP urine immunoassay

Depends on the Brand of Test

Dextromethorphan

Source Krasowski et al., BMC Emerg Med 2009

What It Found

  • Eight unconfirmed Syva EMIT positives in one series had high urine dextromethorphan concentrations.

Keep in Mind

  • Overdose-level exposure was prominent.

Source Rengarajan and Mullins, Clin Toxicol (Phila) 2013

What It Found

  • A separate emergency department study found dextromethorphan was more often recorded when a positive PCP screen failed GC-MS confirmation.

Source Schier, J Emerg Med 2000

What It Found

  • A separate original letter describes a dextromethorphan-associated presumptive PCP urine result.

Keep in Mind

  • The citation does not supply the assay, dose or confirmatory findings.

Test Studied

  • Published letter concerning a urine PCP drug screen

Source Lin et al., J Anal Toxicol 2013

What It Found

  • The authors observed no interference from Dextromethorphan at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

Keep in Mind

  • This is a single challenge level.
  • It cannot rule out interference at a higher concentration or with a different device.

Test Studied

  • NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels

2 sources Krasowski et al., BMC Emerg Med 2009 Rengarajan and Mullins, Clin Toxicol (Phila) 2013

Keep in Mind

  • Routine cough dosing and other manufacturers’ screens may give different results.

Test Studied

  • Syva EMIT and Siemens Syva EMIT II PCP screens

Also cited: Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

Diphenhydramine

Source Krasowski et al., BMC Emerg Med 2009

What It Found

  • One Triage-positive specimen contained a high urine diphenhydramine concentration without GC-MS evidence of PCP.

Keep in Mind

  • The stronger clinical lead involved very high exposure.

Source Rengarajan and Mullins, Clin Toxicol (Phila) 2013

What It Found

  • In another study diphenhydramine was more common in unconfirmed screens, but the difference was statistically inconclusive.

Source Lin et al., J Anal Toxicol 2013

What It Found

  • The authors observed no interference from Diphenhydramine at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

Keep in Mind

  • This is a single challenge level.
  • It cannot rule out interference at a higher concentration or with a different device.

Test Studied

  • NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels

2 sources Krasowski et al., BMC Emerg Med 2009 Rengarajan and Mullins, Clin Toxicol (Phila) 2013

Keep in Mind

  • The frequency at usual doses is unknown.

Test Studied

  • Biosite Triage and Siemens Syva EMIT II PCP screens

Ketamine

Source Shannon, Pediatr Emerg Care 1998

What It Found

  • An early clinical letter reported a PCP-positive screen after ketamine administration.

Test Studied

  • Older clinical urine toxicology screen

Source Gomila et al., J Anal Toxicol 2019

What It Found

  • In a later laboratory evaluation, ketamine did not react on any of five PCP immunoassays.
  • Some related designer drugs did react.

Test Studied

  • Five commercial PCP immunoassays

Both sources Shannon, Pediatr Emerg Care 1998 Gomila et al., J Anal Toxicol 2019

Keep in Mind

  • Ketamine itself has poor support as a general explanation.
  • Check the exact test and avoid applying data on designer analogues to prescribed ketamine.

2-DPMP

Source Beck et al., Drug Test Anal 2014

What It Found

  • At a Desoxypipradrol spike of 4,500 ng/mL, the mean assay response was 26 ng/mL equivalent (0.6% cross-reactivity), above the 25 ng/mL cutoff.

Keep in Mind

  • This is a mean laboratory signal at the stated concentration.
  • The separate clinical urine findings can include metabolites or coexposures.

Test Studied

  • CEDIA Phencyclidine urine assay, cutoff 25 ng/mL

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2-DPMP challenge, Microgenics DRI Phencyclidine gave a positive result at 21 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

A Related Drug the Test Picks Up

3-Methoxyphencyclidine

Source Gomila et al., J Anal Toxicol 2019

What It Found

  • This PCP analog reacted on all five assays in laboratory testing and in urine from two people with confirmed analog overdose.

Keep in Mind

  • A PCP-class screen can respond to closely related substances.
  • It cannot determine which molecule is present.

Test Studied

  • Five commercial PCP immunoassays

4-Methoxyphencyclidine

Source Gomila et al., J Anal Toxicol 2019

What It Found

  • This PCP analog reacted on all five assays in an experimental comparison.

Keep in Mind

  • A PCP-class screen can respond to closely related substances.
  • It cannot determine which molecule is present.

Test Studied

  • Five commercial PCP immunoassays

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-Methoxyphencyclidine challenge, Microgenics DRI Phencyclidine gave a positive result at 1.5 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Benocyclidine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Benocyclidine challenge, Microgenics DRI Phencyclidine gave a positive result at 0.4 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Suspected, but Not Proven

Alprazolam

Source Rengarajan and Mullins, Clin Toxicol (Phila) 2013

What It Found

  • In an emergency department chart study, this medicine was more commonly recorded among PCP screens that failed GC-MS confirmation.

Keep in Mind

  • The authors noted an association with polysubstance use.
  • The analysis did not isolate this medicine as an analytical cross-reactant.

Test Studied

  • Siemens Syva EMIT II PCP

Carvedilol

Source Rengarajan and Mullins, Clin Toxicol (Phila) 2013

What It Found

  • In an emergency department chart study, this medicine was more commonly recorded among PCP screens that failed GC-MS confirmation.

Keep in Mind

  • The authors noted an association with polysubstance use.
  • The analysis did not isolate this medicine as an analytical cross-reactant.

Test Studied

  • Siemens Syva EMIT II PCP

Clonazepam

Source Rengarajan and Mullins, Clin Toxicol (Phila) 2013

What It Found

  • In an emergency department chart study, this medicine was more commonly recorded among PCP screens that failed GC-MS confirmation.

Keep in Mind

  • The authors noted an association with polysubstance use.
  • The analysis did not isolate this medicine as an analytical cross-reactant.

Test Studied

  • Siemens Syva EMIT II PCP

Ibuprofen

Source Martínez Sánchez et al., An Pediatr (Barc) 2011

What It Found

  • A child who had taken therapeutic ibuprofen had a positive MPD Screen 12 result.
  • GC-MS detected ibuprofen and excluded PCP.

Keep in Mind

  • The child also took lamotrigine, carbamazepine and two cough preparations.

Test Studied

  • MPD Screen 12 Test panel (Linear Chemicals)

Source Marchei et al., Ther Drug Monit 2007

What It Found

  • A separate Instant-View report involved an overdose with ibuprofen, metamizole and dextromethorphan.

Test Studied

  • Instant-View multi-test

Both sources Marchei et al., Ther Drug Monit 2007 Martínez Sánchez et al., An Pediatr (Barc) 2011

Keep in Mind

  • Neither case isolates ibuprofen as the cause of the false positive.

Metamizole

Source Marchei et al., Ther Drug Monit 2007

What It Found

  • A letter investigated an overdose involving ibuprofen, metamizole and dextromethorphan in connection with a PCP-positive screen.

Keep in Mind

  • The accessible report metadata do not establish an independent effect of this ingredient.
  • Dextromethorphan has separate evidence and attribution should remain open.

Test Studied

  • Instant-View multi-test in an overdose report

Tested: No False Positive Found

Doxylamine

Source Schaldenbrand et al., Ther Drug Monit 1981

What It Found

  • In a doxylamine intoxication, the PCP immunoassay was negative.
  • A separate gas chromatographic method falsely identified PCP.

Keep in Mind

  • This commonly cited case cannot establish a false positive on an immunoassay.
  • The chromatographic method is distinct from contemporary tandem MS confirmation.

Test Studied

  • EMIT-dau urine immunoassay and historical gas chromatography without mass spectrometry

2,5-Dimethoxyamphetamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2,5-Dimethoxyamphetamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

2-Aminoindane

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2-Aminoindane challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

25B-NBOMe

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 25B-NBOMe challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

25C-NBOMe

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 25C-NBOMe challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

25I-NBOMe

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 25I-NBOMe challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

2C-B

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2C-B challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

2C-C

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2C-C challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

2C-E

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2C-E challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

2C-I

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2C-I challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

2C-T

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2C-T challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

2C-T-2

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2C-T-2 challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

2C-T-4

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2C-T-4 challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

2C-T-7

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2C-T-7 challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

3,4,5-Trimethoxyamphetamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 3,4,5-Trimethoxyamphetamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

3,4-Dimethylmethcathinone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 3,4-Dimethylmethcathinone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

3-Trifluoromethylphenylpiperazine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 3-TFMPP challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

4-CAP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-CAP challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

4-EEC

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-EEC challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

4-Fluoroamphetamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-Fluoroamphetamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

4-Fluoromethamphetamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-Fluoromethamphetamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

4-HO-DET

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-HO-DET challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

4-MEC

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-MEC challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

4-Methylamphetamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-Methylamphetamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

4-Methylthioamphetamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-Methylthioamphetamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

4-TFMPP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-TFMPP challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

5-APB

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-APB challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

5-APDB

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-APDB challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

5-APDI

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-APDI challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

5-IAI

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-IAI challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

5-IT

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-IT challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

5-MeO-AMT

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-MeO-AMT challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

5-MeO-DiPT

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-MeO-DiPT challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

5-MeO-DMT

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-MeO-DMT challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

5-MeO-MiPT

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-MeO-MiPT challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

6-APB

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 6-APB challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Acetaminophen

Source Lin et al., J Anal Toxicol 2013

What It Found

  • The authors observed no interference from Acetaminophen at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

Keep in Mind

  • This is a single challenge level.
  • It cannot rule out interference at a higher concentration or with a different device.

Test Studied

  • NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels

Alpha-methyltryptamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Alpha-methyltryptamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Benzedrone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Benzedrone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Benzylpiperazine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Benzylpiperazine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Bromo-DragonFLY

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Bromo-DragonFLY challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Brompheniramine

Source Thermo Scientific. DRI Phencyclidine Assay instructions for use, 0141, 2025

What It Found

  • Adding 50,000 ng/mL of brompheniramine did not produce a positive PCP result on this assay.

Keep in Mind

  • Brompheniramine can affect some amphetamines screens.
  • That association does not establish a false-positive PCP result.

Test Studied

  • Thermo Scientific DRI Phencyclidine urine assay, 25 ng/mL cutoff

Buphedrone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Buphedrone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Butylone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Butylone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Cathinone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Cathinone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Dibenzylpiperazine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Dibenzylpiperazine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Diethylpropion

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Diethylpropion challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Dimethylamylamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Dimethylamylamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Dimethylone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Dimethylone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Dimethyltryptamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Dimethyltryptamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Dipropyltryptamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Dipropyltryptamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

DiPT

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the DiPT challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

DOB

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the DOB challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

DOC

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the DOC challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

DOET

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the DOET challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

DOI

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the DOI challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

DOM

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the DOM challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Escaline

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Escaline challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Ethcathinone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Ethcathinone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Ethylone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Ethylone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Eutylone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Eutylone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Flephedrone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Flephedrone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

MDAI

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the MDAI challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

MDEA

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the MDEA challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Mephedrone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Mephedrone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Meprobamate

Source Lin et al., J Anal Toxicol 2013

What It Found

  • The authors observed no interference from Meprobamate at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

Keep in Mind

  • This is a single challenge level.
  • It cannot rule out interference at a higher concentration or with a different device.

Test Studied

  • NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels

Mescaline

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Mescaline challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Meta-chlorophenylpiperazine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Meta-chlorophenylpiperazine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Methcathinone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Methcathinone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Methedrone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Methedrone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Methiopropamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Methiopropamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Methylone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Methylone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

MT-45

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the MT-45 challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

N,N-Dimethylcathinone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the N,N-Dimethylcathinone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Pentedrone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Pentedrone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Pentylone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Pentylone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

PMA

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the PMA challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

PMMA

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the PMMA challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine

Prednisone

Source FDA 510(k) K253567. Healgen Accurate Urine Drug Screen Dip Card and Home Urine Drug Test…, 2025

What It Found

  • Prednisone at 100 µg/mL did not cause a positive result in drug-free urine or change the result of urine just below or above this channel’s cutoff.

Keep in Mind

  • The manufacturer challenged the assay with parent prednisone.
  • This does not test all prednisone metabolites or predict the behavior of other devices.

Tests Studied

  • Healgen Accurate multi-drug urine dip card
  • The applicable target and cutoff are 25 ng/mL phencyclidine

WIN 35,428

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the WIN 35,428 challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Phencyclidine